Patency of anastomoses after bilio-intestinal bypass: radioisotope demonstration

Obes Surg. 2001 Oct;11(5):615-8. doi: 10.1381/09608920160557110.

Abstract

Background: Bilio-intestinal bypass (BIB) is effective for the treatment of refractory obesity. BIB permits bile flow into the non-functional jejunum, whereas food transit occurs via the remaining intestine. We used the radioisotope method of 99mTc-Hida cholescintigraphy (HC) in the follow-up of patients.

Methods: 21 patients were studied 3 months to 3 years after BIB with HC. After 3 hours acquisition, images were reviewed by two independent observers. Regions of interest (ROIs) were drawn on images: liver parenchyma, cholecysto-jejunal anastomosis (CC), choledochus (COL). Radioactivity taken up by liver was compared with radioactivity of CC and COL. % radioactivity passing through CC (%CC) and through COL (%COL) were determined. The final parameter, -COL, indicates the radioactive bile which does not pass through the choledochus.

Results: Anastomoses were found patent a few months to 3 years after operation. -COL showed linear correlation with the decrease in cholesterolemia and in body weight in the 1st year after BIB.

Conclusions: HC shows passage of radioactive bile through anastomoses and provides semiquantitative evaluation of bile flux diversion. Bile flux towards the gallbladder and non-functional jejunal limb far exceeds flux directed towards the duodenum via the choledochus.

MeSH terms

  • Adult
  • Anastomosis, Surgical
  • Common Bile Duct / diagnostic imaging*
  • Female
  • Follow-Up Studies
  • Gallbladder / diagnostic imaging*
  • Gallbladder / surgery
  • Humans
  • Intestine, Small / diagnostic imaging*
  • Jejunoileal Bypass*
  • Liver / diagnostic imaging*
  • Male
  • Middle Aged
  • Radionuclide Imaging
  • Radiopharmaceuticals*
  • Technetium Tc 99m Lidofenin*

Substances

  • Radiopharmaceuticals
  • Technetium Tc 99m Lidofenin